Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  ONO PHARMACEUTICAL CO., LTD.    4528   JP3197600004

ONO PHARMACEUTICAL CO., LTD. (4528)

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ( JPY)
Sales 2018 250 163 M
EBIT 2018 -
Net income 2018 40 017 M
Finance 2018 142 659 M
Yield 2018 1,84%
Sales 2019 271 430 M
EBIT 2019 -
Net income 2019 45 230 M
Finance 2019 150 086 M
Yield 2019 1,90%
P/E ratio 2018 33,88
P/E ratio 2019 27,85
EV / Sales2018 5,34x
EV / Sales2019 4,90x
Capitalization 1 479 575 M
More Financials
Company
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of pharmaceutical and diagnostic reagents focusing on prescription pharmaceuticals.Its products include respiratory, digestive, urinary, chemotherapy, hormone, vitamins, and metabolic drugs.The company was founded by Ichibei... 
Sector
Pharmaceuticals
Calendar
06/29Shareholder meeting
More about the company
Surperformance© ratings of ONO PHARMACEUTICAL CO., LT
Trading Rating : Investor Rating :
More Ratings
Latest news on ONO PHARMACEUTICAL CO., LT
06/19 ONO PHARMACEUTICAL : Extended Follow-Up Data Evaluating Opdivo (nivolumab) Shows..
06/13 ONO PHARMACEUTICAL : Announcement on Acquisition and Retirement of Own Shares (9..
06/05 ONO PHARMACEUTICAL : Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) ..
06/05 ONO PHARMACEUTICAL : First Presentation of Efficacy Data from CheckMate -204 Eva..
06/05 ONO PHARMACEUTICAL : Anti-LAG-3 (BMS-986016) in Combination with Opdivo (nivolum..
06/05 ONO PHARMACEUTICAL : Opdivo (nivolumab) Data in Patients with Advanced Cervical,..
06/05 ONO PHARMACEUTICAL : European Commission Approves Bristol-Myers Squibb's Opdivo ..
06/01 ONO PHARMACEUTICAL : Notice to Convene the 69th Ordinary General Shareholders' M..
05/31 ARRAY BIOPHARMA INC. (NASDAQ : ARRY) Files An 8-K Entry into a Material Definiti..
05/31 ONO PHARMACEUTICAL : Concludes a License Agreement with Array Biopharma related ..
More news
Sector news : Generic Pharmaceuticals
06:41pDJHow Third Point's Nestlé Move Could Affect L'Oréal
05:14p TSX down as softer commodity prices weigh on resource shares
06/23DJSAMSUNG ELECTRONICS : Makes Play for Drug Market With Version of Humira -- Updat..
06/23DJSAMSUNG ELECTRONICS : Makes Big Play in Drug Market With Cheaper Version of Bloc..
06/23DJOne of the Last Untapped Blockbuster Diseases? Drug Companies Race to Find a ..
More sector news : Generic Pharmaceuticals
Latest Tweets
06/13ONO PHARMACEUTICAL : Announcement on Acquisition and Retirement of Own Shares.. 
05/31$ARRY (+3.1% pre) Array BioPharma & Ono Pharmaceutical Announce A License..
2
05/31BRIEF-Ono Pharmaceutical concludes a license agreement with array biopharma r.. 
05/31Array BioPharma And Ono Pharmaceutical Co., Ltd. Announce A License, Developm.. 
05/31BRIEF-Array Biopharma & Ono Pharmaceutical announce partnership for two N.. 
More tweets
Qtime:18
News from SeekingAlpha
06/22 Only Bristol Bucks Big Pharma's Drive For External Reliance
06/02 3 THINGS IN BIOTECH YOU SHOULD LEARN : June 2, 2017
05/31 Array out-licenses binimetinib and encorafenib to Ono Pharma for Japan and So..
05/10 BRISTOL-MYERS SQUIBB : A Deep Dive Finds Some Pearls
01/23 Bristol Catches A Break At Last
Advertisement
Chart ONO PHARMACEUTICAL CO., LT
Duration : Period :
ONO PHARMACEUTICAL CO., LT Technical Analysis Chart | 4528 | JP3197600004 | 4-Traders
Full-screen chart
Technical analysis trends ONO PHARMACEUTICA...
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Average target price 2 589  JPY
Spread / Average Target 3,1%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Gyo Sagara President & Representative Director
Shozo Matsuoka Executive Officer & Manager-Medical Affairs
Kazuhito Kawabata Director & Managing Executive Officer
Hiroshi Awata Director, EVP & General Manager-Development
Isao Ono Director & Managing Executive Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ONO PHARMACEUTICAL CO...-1.19%13 291
OTSUKA HOLDINGS CO LTD-3.93%24 579
SUN PHARMACEUTICAL IND..-13.40%20 235
SHANGHAI FOSUN PHARMAC..34.75%11 068
ASPEN PHARMACARE HOLDI..-0.82%10 049
CADILA HEALTHCARE LTD47.85%8 345
More Results